3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myeloid, Acute
2
Breast Neoplasms
2
Vomiting
1
Postoperative Cognitive Complications
1
Pathologic Processes
1
Neoplasms
1
Nausea
1
Malnutrition
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Liver Diseases
1
Hematologic Neoplasms
1
Gastrointestinal Neoplasms
1
Frailty
1
Emergence Delirium
1
Carcinoma, Hepatocellular
1
Breast Cancer Female
1
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Control Groups
×
90 days
×
Clear all
No trials found.